Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma.

Authors:
Gunnar Schalasta
Gunnar Schalasta
Institute for Virology
Germany
Martin Enders
Martin Enders
Laboratory Prof. Enders and Partners & Institute of Virology
Germany

Clin Chem Lab Med 2016 Mar;54(3):493-9

Background: Quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma has become the standard of care in the management of HIV-infected patients. There are several commercially available assays that have been implemented for the detection of HIV-1 RNA in plasma. Here, the new Hologic Aptima® HIV-1 Quant Dx assay (Aptima HIV) was compared to the Roche COBAS® TaqMan® HIV-1 Test v2.0 for use with the High Pure System (HPS/CTM).

Methods: The performance characteristics of the assays were assessed using commercially available HIV reference panels, dilution of the WHO 3rd International HIV-1 RNA International Standard (WHO-IS) and plasma from clinical specimens. Assay performance was determined by linear regression, Deming correlation analysis and Bland-Altman analysis.

Results: Testing of HIV-1 reference panels revealed excellent agreement. The 61 clinical specimens quantified in both assays were linearly associated and strongly correlated.

Conclusions: The Aptima HIV assay offers performance comparable to that of the HPS/CTM assay and, as it is run on a fully automated platform, a significantly improved workflow.

Download full-text PDF

Source
http://dx.doi.org/10.1515/cclm-2015-0522DOI Listing

Still can't find the full text of the article?

Let us try to send a request to the authors directly.
March 2016
239 Reads

Publication Analysis

Top Keywords

hiv-1 rna
16
rna plasma
12
hiv-1
9
reference panels
8
pure system
8
high pure
8
clinical specimens
8
aptima hiv
8
quant assay
8
hiv-1 quant
8
assay
6
hiv compared
4
deming correlation
4
cobas® taqman®
4
taqman® hiv-1
4
linear regression
4
roche cobas®
4
regression deming
4
compared roche
4
aptima® hiv-1
4

References

(Supplied by CrossRef)
Changes in plasma HIV RNA levels and CD lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure VA Cooperative Study Group on AIDS
Brien et al.
Ann Intern Med 1997
Plasma viral load and CD lymphocytes as prognostic markers of HIV - infection
Mellors et al.
Ann Intern Med 1997
Comparative evaluation of the Artus HIV - QS - RGQ assay and the Abbott RealTime HIV - assay for the quantification of HIV - RNA in plasma
Garcia et al.
J Clin Virol 2013
Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors
Wiesmann et al.
Med Microbiol Immunol 2015
Monitoring plasma HIV - RNA levels in addition to CD lymphocyte count improves assessment of antiretroviral therapeutic response
Hughes et al.
Ann Intern Med 1997
Genetic and phylogenetic analysis of env subtypes G and H in central Africa
Janssens et al.
Aids Res Hum Retroviruses 1994

Similar Publications